rs201661705

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006517.5(SLC16A2):​c.265G>A​(p.Ala89Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,209,395 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A89P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000097 ( 0 hom., 3 hem., cov: 24)
Exomes 𝑓: 0.000034 ( 0 hom. 8 hem. )

Consequence

SLC16A2
NM_006517.5 missense

Scores

1
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.863

Publications

0 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009373546).
BP6
Variant X-74421902-G-A is Benign according to our data. Variant chrX-74421902-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 589223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000973 (11/113006) while in subpopulation AMR AF = 0.00102 (11/10835). AF 95% confidence interval is 0.000569. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC16A2NM_006517.5 linkc.265G>A p.Ala89Thr missense_variant Exon 1 of 6 ENST00000587091.6 NP_006508.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC16A2ENST00000587091.6 linkc.265G>A p.Ala89Thr missense_variant Exon 1 of 6 1 NM_006517.5 ENSP00000465734.1
SLC16A2ENST00000636771.1 linkn.10G>A non_coding_transcript_exon_variant Exon 1 of 7 5 ENSP00000490445.1

Frequencies

GnomAD3 genomes
AF:
0.0000885
AC:
10
AN:
112961
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000924
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000189
AC:
33
AN:
174251
AF XY:
0.000127
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00118
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000231
GnomAD4 exome
AF:
0.0000337
AC:
37
AN:
1096389
Hom.:
0
Cov.:
32
AF XY:
0.0000221
AC XY:
8
AN XY:
362199
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26357
American (AMR)
AF:
0.000996
AC:
35
AN:
35136
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19335
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53889
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40194
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3750
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841581
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45971
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000973
AC:
11
AN:
113006
Hom.:
0
Cov.:
24
AF XY:
0.0000853
AC XY:
3
AN XY:
35156
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31210
American (AMR)
AF:
0.00102
AC:
11
AN:
10835
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2658
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3546
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2754
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6278
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53288
Other (OTH)
AF:
0.00
AC:
0
AN:
1540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000117
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spastic paraplegia Benign:1
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 12, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Sep 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
9.9
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.0094
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.86
PrimateAI
Benign
0.47
T
Sift4G
Benign
0.32
T
Polyphen
0.043
B
Vest4
0.041
MVP
0.082
MPC
0.86
ClinPred
0.019
T
GERP RS
1.4
PromoterAI
0.014
Neutral
Varity_R
0.061
gMVP
0.21
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201661705; hg19: chrX-73641737; API